- Nova Ltd (NASDAQ:NVMI) reported a Q1 2023 revenue decline of 1% Y/Y to $132.2 million, beating the consensus of $130.1 million.
- The company witnessed solid bookings for materials metrology, such as METRION, VERAFLEX and ELIPSON platforms.
- Adjusted EPS declined 5% Y/Y to $1.23, beating the consensus of $1.04.
- Gross margin expanded to 58% from 56% in the first quarter of 2022, led by higher software revenues and a favorable product mix.
- Operating expenses increased to $41.5 million from $37.6 million a year ago.
- Cash and equivalents stood at $389.4 million at the end of the quarter.
- Outlook: Nova expects revenues of $117 million to $125 million (consensus: $124.87 million) and adjusted EPS of $0.92 to $1.06 (vs. consensus: $0.94) in Q2 2023.
- “We’re encouraged by the record bookings for our materials metrology solutions and believe our positioning in this strategic domain is a growth engine for years to come. As our industry charts a path forward, navigating a host of global volatile conditions, we at Nova remain focused on our strategic plans and infrastructure investments that will enable our long-term growth,” said Gaby Waisman, President and CEO.
- Price Action: NVMI shares are trading higher by 0.78% at $91.99 on the last check Thursday.
Cannabis Chart Of The Week: Who’s Growing In Florida, And Has The State Gotten Ahead Of Itself?
Florida is often considered one of the most critical states in terms of growing legal cannabis sales. The State is estimated to have approximately $2.6B in 2023 legal sales, representing a per capita consumption of about $118 based on the total population or $145 based on adult population.
